Recovery by splenectomy in patients with relapsed thrombotic thrombocytopenic purpura and treatment failure to plasma exchange
- PMID: 7660138
- DOI: 10.1055/s-2007-1000391
Recovery by splenectomy in patients with relapsed thrombotic thrombocytopenic purpura and treatment failure to plasma exchange
Abstract
Thrombotic thrombocytopenic purpura is a serious, potentially fatal disease, and conventional plasma exchange appears to be the best initial therapy. Following this approach, survival in 90% of patients is available. In patients with relapse and treatment failure to plasma exchange, splenectomy is recommended. The rationale for splenectomy and the relevant pathomechanisms involved are obscure. In the present paper two patients with TTP are reported who first responded to conventional treatment strategies but later relapsed. Resumption of previous therapy was not able to continuously maintain normal platelet levels. Thus, splenectomy was considered to be indicated. In contrast to former reports, repeated cycles of conventional plasma exchanges were performed until a transient steady state (12 hrs) of the platelet counts occurred. Then splenectomy was performed immediately and, in contrast to former reports, no reinstitution of treatment was necessary after splenectomy. In addition no postoperative complications (bleeding, neurologic impairment) have been observed. This favorable outcome might be due to the strategy of repeated conventional plasma exchange procedures. The follow-up shows now event free disease for 2 years.
Similar articles
-
Role of splenectomy in patients with refractory or relapsed thrombotic thrombocytopenic purpura.J Clin Apher. 2003;18(2):51-4. doi: 10.1002/jca.10053. J Clin Apher. 2003. PMID: 12874815
-
Splenectomy for the treatment of thrombotic thrombocytopenic purpura.Br J Haematol. 2005 Sep;130(5):768-76. doi: 10.1111/j.1365-2141.2005.05681.x. Br J Haematol. 2005. PMID: 16115135 Review.
-
Response to plasma exchange and splenectomy in thrombotic thrombocytopenic purpura. A 10-year experience at a single institution.Arch Intern Med. 1992 Apr;152(4):791-6. Arch Intern Med. 1992. PMID: 1558437
-
Outcomes in the treatment of thrombotic thrombocytopenic purpura with splenectomy: a retrospective cohort study.Am J Hematol. 2006 Dec;81(12):895-900. doi: 10.1002/ajh.20678. Am J Hematol. 2006. PMID: 16888787
-
[Treatment of thrombocytopenic thrombotic purpura].Sangre (Barc). 1997 Feb;42(1):53-61. Sangre (Barc). 1997. PMID: 9229804 Review. Spanish. No abstract available.
Cited by
-
Thrombotic Thrombocytopenic Purpura Associated with Myelodysplastic Syndrome.Cureus. 2020 Mar 22;12(3):e7364. doi: 10.7759/cureus.7364. Cureus. 2020. PMID: 32328376 Free PMC article.
-
Case series: splenectomy: does it still play a role in the management of thrombotic thrombocytopenic purpura?Can J Surg. 2010 Oct;53(5):349-55. Can J Surg. 2010. PMID: 20858382 Free PMC article. Review.
-
Thrombotic Thrombocytopenic Purpura Associated with Dermatomyositis.Cureus. 2018 Aug 20;10(8):e3161. doi: 10.7759/cureus.3161. Cureus. 2018. PMID: 30357036 Free PMC article.
-
[Multi-organ involvement in recurrent Moschcowitz disease. Splenectomy as ultima ratio in a therapeutic dilemma?].Med Klin (Munich). 1998 Oct 15;93(10):624-6. doi: 10.1007/BF03042678. Med Klin (Munich). 1998. PMID: 9849054 German.
-
Good practice statements (GPS) for the clinical care of patients with thrombotic thrombocytopenic purpura.J Thromb Haemost. 2020 Oct;18(10):2503-2512. doi: 10.1111/jth.15009. Epub 2020 Sep 11. J Thromb Haemost. 2020. PMID: 32914535 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources